Establishment of segawa disease specific iPS cells and use to create a drug screening platform
碩士 === 中國醫藥大學 === 生物醫學研究所碩士班 === 106 === Segawa disease is a rare disorder caused by GTP cyclohydrolase 1 (GCH1) gene mutation presenting gait disturbance and dystonia. The clinical symptoms like Parkinson''s disease. Segawa disease lacked effective therapeutic methods. The traditional dru...
Main Authors: | Yu-Chen Lin, 林毓貞 |
---|---|
Other Authors: | 劉詩平 |
Format: | Others |
Language: | zh-TW |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/zr57j7 |
Similar Items
-
Levodopa Dose-Limiting Dyskinesias in Treatment of Segawa Disease
by: J Gordon Millichap
Published: (2012-07-01) -
Good obstetric outcome in a patient with Segawa disease
by: Takashi Watanabe, et al.
Published: (2012-07-01) -
Schizophrenia with segawa syndrome: A therapeutic challenge
by: Disha Devang Parikh, et al.
Published: (2020-01-01) -
Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease.
by: Naoki Yahata, et al.
Published: (2011-01-01) -
Beyond the Classic Segawa Disease, -Associated Neurodegenerative Parkinsonism: Practical Considerations for Physicians
by: Jirat Chenbhanich, et al.
Published: (2017-05-01)